A molecular discovery platform leverages advanced technologies like synthetic libraries, hybridoma, Bispecific Antibody, single B cell sorting, and AI to identify and develop novel antibodies efficiently.
Our pilot R&D and production platform excels in small-scale processes and Fed-Batch culture, using advanced purification technologies like affinity and ion exchange chromatography. We produce high-purity antibody and protein solutions, and various drug products with industry-leading filling accuracy.
A quality control platform conducts comprehensive tests including molecular weight, sequence coverage, disulfide bond location, peptide mapping, N/C terminal sequencing, post-translational modifications, DAR value, and unknown peak identification.
Discover the precision and reliability of Hotgen IVD products. Contact us today to enrich your product portfolio & enhance your diagnostic capabilities and patient care.
From May 20–22, 2026, the KIHE 2026 Kazakhstan International Healthcare Exhibition officially opened at the Atakent Exhibition Centre in Almaty.At the exhibition, Beijing Hotgen Biotech Co., Ltd. pre...
In May 2026, Hotgen accelerated its global expansion by making a simultaneous presence at two key regional medical exhibitions — Vietnam Medi-Pharm 2026 and MEDITEX Bangladesh 2026. Showcasing compre...